Dr. Richardson received her PhD in Epidemiology & Biostatistics at McGill University, where she studied the natural history of HPV infections and cervical neoplasia. She is Associate Professor in the Department of Public Health Sciences and joined the Canadian Cancer Trials Group in 2004 where she is the current Senior Investigator for the Supportive Care Committee and provides oversight for trials with a focus on breast cancer prevention. Her research also involves tissue and blood banking for future biomarker development projects and evaluating quality of life data from clinical trials. Dr. Richardson who bridges the Division of Cancer Clinical Trials (Canadian Cancer Trials Group) and Cancer Care and Epidemiology in the Queen’s Cancer Research Institute also conducts etiologic research primarily focused on understanding specific environmental causes of breast cancer and their interaction with genetic and hormonal factors and elucidating intermediate mechanisms in the causal pathway to breast cancer.
Areas of expertise: Cancer epidemiology, breast cancer prevention trials, Human papillomavirus (HPV) infections, Health-related quality of life
Research interests: Etiology of breast and cervical cancer, intermediate markers for breast cancer, biomarkers of toxicity and efficacy in chemoprevention trials, menopause-specific health related quality of life
Current trials: MAP.3, SC.26 and BL.13 sub-study (in development)
For a full list of publications please visit PubMed